Older People with Type 2 Diabetes: Glycemic Control and Hypoglycemia Risk with New Insulin Glargine 300 U/mL

被引：0
|
作者：
Yale, Jean-Francois
Aroda, Vanita R.
Charbonnel, Bernard
Ritzel, Robert
Merino-Trigo, Ana
Stella, Peter
Grisoni, Marie-Lise
Sinclair, Alan J.
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
991-P
引用
收藏
页码：A252 / A252
页数：1
相关论文
共 50 条
  • [1] GLYCEMIC CONTROL AND HYPOGLYCEMIA WITH NEW INSULIN GLARGINE 300 U/ML IN PEOPLE WITH TYPE 1 DIABETES (EDITION 4)
    Home, P. D.
    Bergenstal, R.
    Riddle, M. C.
    Rojeski, M.
    Espinasse, M.
    Bolli, G. B.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A104 - A105
  • [2] Older people with type 2 diabetes: glycaemic control and hypoglycaemia risk with new insulin glargine 300 U/ml (Gla-300)
    Stella, P.
    Aroda, V.
    Charbonnel, B.
    Ritzel, R.
    Merino-Trigo, A.
    Grisoni, M. -L.
    Sinclair, A. J.
    Yale, J. -F.
    [J]. DIABETOLOGIA, 2015, 58 : S473 - S473
  • [3] New Insulin Glargine 300 U/ml: Glycemic Control and Hypoglycemia in Insulin Naive People with T2DM (EDITION 3)
    Bolli, Geremia B.
    Riddle, Matthew C.
    Bergenstal, Richard M.
    Ziemen, Monika
    Sestakauskas, Kastytis
    Goyeau, Harmonie
    Home, Phillip D.
    [J]. DIABETES, 2014, 63 : A19 - A19
  • [4] Improved Glycemic Control with Insulin Glargine 300 U/mL vs. Glargine 100 U/mL in Type 1 Diabetes
    Paola, Lucidi
    Cioli, Patrizia
    Candeloro, Paola
    Andreoli, Anna Marinelli
    Bolli, Geremia B.
    Fanelli, Carmine G.
    Porcellati, Francesca
    [J]. DIABETES, 2020, 69
  • [5] Glycaemic variability and risk for hypoglycaemia on insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes
    Kovatchev, B.
    Meng, Z.
    Breton, M.
    Leroy, B.
    Cali, A.
    Perfetti, R.
    [J]. DIABETOLOGIA, 2017, 60 : S36 - S37
  • [6] INSULIN GLARGINE 300 U/ML IS ASSOCIATED WITH LESS WEIGHT GAIN WHILE MAINTAINING GLYCEMIC CONTROL AND LOW RISK OF HYPOGLYCEMIA COMPARED WITH INSULIN GLARGINE 100 U/ML IN AN AGING POPULATION WITH TYPE 2 DIABETES
    Munshi, Medha N.
    Gill, Jasvinder
    Chao, Jason
    Nikonova, Elena V.
    Patel, Meenakshi
    [J]. ENDOCRINE PRACTICE, 2018, 24 (02) : 143 - 149
  • [7] Age, BMI, and Diabetes Duration: Effect on Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes (T2DM)
    Twigg, Stephen M.
    Escalada, Javier
    Grisoni, Marie-Lise
    Stella, Peter
    Merino-Trigo, Ana
    Lavalle Gonzalez, Fernando J.
    Cariou, Bertrand
    Meneghini, Luigi F.
    [J]. DIABETES, 2015, 64 : A260 - A260
  • [8] AGE OF DIABETES ONSET: GLYCEMIC CONTROL AND HYPOGLYCEMIA BENEFIT WITH NEW INSULIN GLARGINE 300U/ML IN T2DM
    Twigg, S.
    Khunti, K.
    Forst, T.
    Janez, A.
    Merino-Trigo, A.
    Stella, P.
    Grisoni, M. L.
    Galstyan, G.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A45 - A45
  • [9] Glycaemic control and hypoglycaemia with new insulin glargine 300 U/mL in people with type 1 diabetes (EDITION 4)
    Home, P. D.
    Bergenstal, R. M.
    Riddle, M. C.
    Ziemen, M.
    Rojeski, M.
    Espinasse, M.
    Bolli, G. B.
    [J]. DIABETOLOGIA, 2014, 57 : S69 - S70
  • [10] NEW INSULIN GLARGINE 300 U/ML: GLYCEMIC CONTROL AND HYPOGLYCEMIA IN A META-ANALYSIS OF EDITION CLINICAL TRIALS IN PEOPLE WITH T2DM
    Ritzel, R. A.
    Roussel, R.
    Bolli, G. B.
    Vinet, L.
    Yki-Jarvinen, H.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A16 - A17
12345